Study of Biomarkers of Airway Inflammation (0000-128)

NCT00869596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Airway Inflammation

Interventions

DRUG: fluticasone propionate
DRUG: Comparator: Placebo to fluticasone
DRUG: Comparator: Lipopolysaccharide (LPS)
DRUG: Comparator: albuterol

Sponsor

Merck Sharp & Dohme LLC